Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Net Issuance of Common Stock
Abbott Laboratories
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
8%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Issuance of Common Stock
-$500m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Issuance of Common Stock
$182m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Net Issuance of Common Stock
-$709.7m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
|
Stryker Corp
NYSE:SYK
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Issuance of Common Stock
$310.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
See Also
What is Abbott Laboratories's Net Issuance of Common Stock?
Net Issuance of Common Stock
-1.1B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Net Issuance of Common Stock amounts to -1.1B USD.
What is Abbott Laboratories's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
8%
Over the last year, the Net Issuance of Common Stock growth was 43%. The average annual Net Issuance of Common Stock growth rates for Abbott Laboratories have been -74% over the past three years , -74% over the past five years , and 8% over the past ten years .